Incyte Corporation INCY NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

82/100

6/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Incyte Corporation (INCY), dont 16 achats et 33 ventes. Le total des achats d'initiés s'élève à $8.39M et le total des ventes d'initiés à $37.61M.

Les initiés notables ayant une activité récente comprennent Harrigan Edmund, Baker Bros. Advisors Lp, Clancy Paul J. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — INCY

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-31	Harrigan Edmund	Director	Attribution de RSU	269	$94.12	$25.32K	21,122
2026-03-31	Baker Bros. Advisors Lp	10 Percent Owner	Attribution de RSU	421	-	-	2,818,039
2026-03-31	Clancy Paul J	Director	Attribution de RSU	265	$94.12	$24.94K	23,741
2026-03-25	Trotta Matteo	EVP, GM, Dermatology Us	Retenue Fiscale RSU	537	$92.23	$49.53K	14,882
2026-03-17	Cagnoni Pablo J	President, R&d	Exercice d'Options (Vente)	7,166	$61.18	$438.42K	9,102
2026-02-19	Cagnoni Pablo J	President, R&d	Exercice d'Options (Vente)	13,093	$61.76	$808.62K	7,182
2026-02-02	Morrissey Michael James	EVP, Head of Tech. Operations	Retenue Fiscale RSU	185	$102.67	$18.99K	34,065
2026-02-02	Heeson Lee	EVP, Head of Incyte Intl	Retenue Fiscale RSU	111	$102.67	$11.4K	38,041
2026-01-20	Morrissey Michael James	EVP, Head of Tech. Operations	Retenue Fiscale RSU	429	$102.62	$44.02K	34,250
2026-01-16	Cagnoni Pablo J	President, R&d	Attribution de RSU	28,475	$106.21	$3.02M	28,475
2026-01-16	Stein Steven H	EVP & Chief Medical Officer	Attribution de RSU	19,932	$106.21	$2.12M	19,932
2026-01-16	Morrissey Michael James	EVP, Head of Tech. Operations	Attribution de RSU	7,426	-	-	34,679
2026-01-16	Tray Thomas	Principal Accounting Officer	Attribution de RSU	2,425	$106.21	$257.56K	2,425
2026-01-16	Trotta Matteo	EVP, GM, Dermatology Us	Attribution de RSU	8,542	$106.21	$907.25K	8,542
2026-01-16	Heeson Lee	EVP, Head of Incyte Intl	Attribution de RSU	8,911	-	-	38,152
2026-01-16	Issa Mohamed Khairie	EVP, Head of Us Oncology	Attribution de RSU	14,237	$106.21	$1.51M	14,237
2026-01-16	Mayes Patrick A	EVP & Chief Scientific Officer	Attribution de RSU	4,218	$106.21	$447.99K	4,218
2026-01-07	Issa Mohamed Khairie	EVP, Head of Us Oncology	Vente Informative	10,856	$109.07	$1.18M	66,132
2026-01-06	Issa Mohamed Khairie	EVP, Head of Us Oncology	Retenue Fiscale RSU	8,264	$106.66	$881.44K	76,988
2026-01-05	Stein Steven H	EVP & Chief Medical Officer	Vente Informative	15,634	$101.70	$1.59M	34,203
2025-12-31	Harrigan Edmund	Director	Attribution de RSU	245	$98.77	$24.2K	20,853
2025-12-31	Baker Bros. Advisors Lp	10 Percent Owner	Attribution de RSU	328	-	-	2,817,618
2025-12-31	Clancy Paul J	Director	Attribution de RSU	241	$98.77	$23.8K	23,476
2025-12-31	Stein Steven H	EVP & Chief Medical Officer	Retenue Fiscale RSU	13,292	$98.77	$1.31M	49,837
2025-12-31	Morrissey Michael James	EVP, Head of Tech. Operations	Retenue Fiscale RSU	254	$98.77	$25.09K	27,253
2025-12-19	Tray Thomas	Principal Accounting Officer	Exercice d'Options (Vente)	1,044	$95.76	$99.97K	-
2025-12-18	Tray Thomas	Principal Accounting Officer	Vente Informative	600	$98.25	$58.95K	22,973
2025-12-17	Morrissey Michael James	EVP, Head of Tech. Operations	Vente Informative	4,323	$97.26	$420.45K	27,507
2025-12-16	Morrissey Michael James	EVP, Head of Tech. Operations	Vente Informative	53,175	$97.29	$5.17M	31,830
2025-12-11	Mayes Patrick A	EVP & Chief Scientific Officer	Vente Informative	255	$94.94	$24.21K	60,011
2025-12-10	Mayes Patrick A	EVP & Chief Scientific Officer	Vente Informative	5,553	$95.58	$530.76K	60,266
2025-12-08	Hoppenot Herve	Director	Retenue Fiscale RSU	2,843	$96.70	$274.92K	326,803
2025-12-02	Stein Steven H	EVP & Chief Medical Officer	Vente Informative	20,105	$102.51	$2.06M	63,129
2025-12-01	Stein Steven H	EVP & Chief Medical Officer	Retenue Fiscale RSU	17,093	$102.04	$1.74M	83,234
2025-12-01	Morrissey Michael James	EVP, Head of Tech. Operations	Retenue Fiscale RSU	326	$102.04	$33.27K	85,838
2025-12-01	Hoffman Richard A.	Officer	Inconnu	-	-	-	-
2025-12-01	Hoffman Richard A.	EVP & General Counsel	Attribution de RSU	9,466	-	-	9,466
2025-11-24	Tray Thomas	Principal Accounting Officer	Vente Informative	600	$103.00	$61.8K	23,573
2025-11-21	Tray Thomas	Principal Accounting Officer	Vente Informative	169	$102.00	$17.24K	24,173
2025-11-17	Denton Sheila A.	EVP & General Counsel	Exercice d'Options (Vente)	278	$64.25	$17.86K	8,883
2025-11-10	Hoppenot Herve	Director	Vente Informative	187,500	$105.46	$19.77M	329,646
2025-11-05	Stein Steven H	EVP & Chief Medical Officer	Exercice d'Options (Vente)	1,194	$83.83	$100.09K	-
2025-11-04	Denton Sheila A.	EVP & General Counsel	Exercice d'Options (Vente)	598	$58.06	$34.72K	13,765
2025-11-03	Heeson Lee	EVP, Head of Incyte Intl	Vente Informative	3,074	$94.02	$289.02K	29,241
2025-10-15	Denton Sheila A.	EVP & General Counsel	Exercice d'Options (Vente)	277	$64.25	$17.8K	9,161
2025-10-03	Denton Sheila A.	EVP & General Counsel	Vente Informative	3,501	$85.54	$299.48K	26,569
2025-10-02	Denton Sheila A.	EVP & General Counsel	Exercice d'Options (Vente)	599	$58.06	$34.78K	14,363
2025-10-01	Heeson Lee	EVP, Head of Incyte Intl	Retenue Fiscale RSU	463	$86.70	$40.14K	32,315
2025-10-01	Mayes Patrick A	EVP & Chief Scientific Officer	Retenue Fiscale RSU	1,569	$86.70	$136.03K	65,819
2025-09-30	Harrigan Edmund	Director	Attribution de RSU	289	$84.81	$24.51K	20,608

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration